Recent content by average

  1. A

    bronchitol

    The Europeans have voted bronchitol down and the company is in the process of appealing the decision. It appears that while bronchitol demonstrated a > 7% increase in FEV1 over 26 weeks against baseline in over 300 patients, that there was a strong placebo responce particularly in adolecents...
  2. A

    bronchitol

    The Europeans have voted bronchitol down and the company is in the process of appealing the decision. It appears that while bronchitol demonstrated a > 7% increase in FEV1 over 26 weeks against baseline in over 300 patients, that there was a strong placebo responce particularly in adolecents...
  3. A

    bronchitol

    The Europeans have voted bronchitol down and the company is in the process of appealing the decision. It appears that while bronchitol demonstrated a > 7% increase in FEV1 over 26 weeks against baseline in over 300 patients, that there was a strong placebo responce particularly in adolecents...
  4. A

    Europeans vote down dry powder mannitol

    I suppose what I'm saying is the CFF is a global advocacy body but doesn't appear to openly support new CF therapies unless it has a financial interest in them (ie Vertex, nebulized saline). This mannitol stuff seems to work, so why doesn't the CFF openly apply some advocacy pressure? Agree...
  5. A

    Europeans vote down dry powder mannitol

    I suppose what I'm saying is the CFF is a global advocacy body but doesn't appear to openly support new CF therapies unless it has a financial interest in them (ie Vertex, nebulized saline). This mannitol stuff seems to work, so why doesn't the CFF openly apply some advocacy pressure? Agree...
  6. A

    Europeans vote down dry powder mannitol

    I suppose what I'm saying is the CFF is a global advocacy body but doesn't appear to openly support new CF therapies unless it has a financial interest in them (ie Vertex, nebulized saline). This mannitol stuff seems to work, so why doesn't the CFF openly apply some advocacy pressure? Agree...
  7. A

    Europeans vote down dry powder mannitol

    It appears our friends in Europe have decided that an 6 to 8 percent improvements in lung function (2 clinical trials) in over 600 CF patients over a 12 months is not an sufficient improvement in FEV1 to justify approving the dry powder for marketing approval in Europe.  You have to wonder why...
  8. A

    Europeans vote down dry powder mannitol

    It appears our friends in Europe have decided that an6 to 8 percent improvements in lung function (2 clinical trials)in over 600 CF patientsover a 12 months is not an sufficient improvementin FEV1 tojustify approving thedry powder for marketing approval in Europe.You have to wonder why...
  9. A

    Europeans vote down dry powder mannitol

    <p>It appears our friends in Europe have decided that an6 to 8 percent improvements in lung function (2 clinical trials)in over 600 CF patientsover a 12 months is not an sufficient improvementin FEV1 tojustify approving thedry powder for marketing approval in Europe.You have to wonder why...
See more
Top